CareDx, Inc. (CDNA) financial statements (2021 and earlier)

Company profile

Business Address 1 TOWER PLACE
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:225386517173036
Cash and cash equivalents135386517173036
Short-term investments90      
Other undisclosed cash, cash equivalents, and short-term investments(0)      
Receivables3524103   
Inventory, net of allowances, customer advances and progress billings10656511
Inventory10656511
Other undisclosed current assets4421443
Total current assets:273728127273440
Noncurrent Assets
Operating lease, right-of-use asset15 
Property, plant and equipment11442322
Intangible assets, net (including goodwill)68694545471919
Goodwill24241212141212
Intangible assets, net (excluding goodwill)444633333377
Restricted cash and investments00010   
Other noncurrent assets11  000
Other undisclosed noncurrent assets 5  000
Total noncurrent assets:95805057502121
TOTAL ASSETS:36915213184775661
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3321169954
Accounts payable10653321
Accrued liabilities5321111
Employee-related liabilities181295422
Interest and dividends payable   01  
Deferred revenue4 
Debt  0162336
Deferred rent credit  0
Derivative instruments and hedges, liabilities   15   
Business combination, contingent consideration, liability11     
Deferred revenue and credits0001
Contract with customer, liability4 
Other undisclosed current liabilities32933811
Total current liabilities:69352043411011
Noncurrent Liabilities
Long-term debt and lease obligation16 0181136
Long-term debt, excluding current maturities   181135
Capital lease obligations000 0
Operating lease, liability16 
Liabilities, other than long-term debt245101033
Deferred revenue and credits2222
Deferred rent credit  0
Deferred tax liabilities, net356  
Deferred income tax liabilities1 
Other liabilities0411100
Business combination, contingent consideration, liability   2011
Other undisclosed noncurrent liabilities41410195 (0)
Total noncurrent liabilities:2218154716169
Total liabilities:91533590572620
Stockholders' equity
Stockholders' equity attributable to parent, including:2789996(6)192941
Common stock0000000
Additional paid in capital632438412264236203201
Accumulated other comprehensive loss(2)(5)(4)(2)(4)  
Accumulated deficit(353)(334)(312)(268)(213)(173)(159)
Warrants and rights outstanding   19   
Other undisclosed stockholders' equity attributable to parent   (19)   
Stockholders' equity attributable to noncontrolling interest   00  
Total stockholders' equity:2789996(6)202941
TOTAL LIABILITIES AND EQUITY:36915213184775661

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1921277748412827
Revenue, net48402827
Cost of revenue (45)(0)(9)(10)(10)(9)
Cost of goods and services sold  (0)(9)(10)(10)(9)
Gross profit:192827639301819
Operating expenses(215)(106)(92)(69)(78)(40)(26)
Other undisclosed operating income  0910109
Operating income (loss):(23)(25)(16)(20)(37)(12)1
Nonoperating income (expense)31(0)(1)(2)(0)0
Other nonoperating income (expense)(1)(1)(0)(1)(2)(0)0
Interest and debt expense      (0)
Income (loss) from continuing operations before equity method investments, income taxes:(20)(24)(16)(22)(39)(12)1
Other undisclosed loss from continuing operations before income taxes  (32)(35)(2)(2)(2)
Loss from continuing operations before income taxes:(20)(24)(48)(57)(41)(14)(1)
Income tax benefit12122 2
Net income (loss):(19)(22)(47)(56)(40)(14)1
Net income attributable to noncontrolling interest  000  
Net income (loss) available to common stockholders, basic:(19)(22)(47)(55)(39)(14)1
Interest on convertible debt      0
Other undisclosed net loss available to common stockholders, diluted      (0)
Net income (loss) available to common stockholders, diluted:(19)(22)(47)(55)(39)(14)1

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(19)(22)(47)(56)(40)(14)1
Other undisclosed comprehensive income (loss)3(1)(2)1(4)  
Comprehensive income (loss):(16)(23)(49)(54)(43)(14)1
Comprehensive income, net of tax, attributable to noncontrolling interest  000  
Comprehensive income (loss), net of tax, attributable to parent:(16)(23)(49)(54)(43)(14)1

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: